SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla - Quaterly Results

26 Jul 2023 Evaluate
The Revenue for the quarter ended  June 2023 of Rs. 43181.90 millions grew by 12.27 % from Rs. 38461.40 millions.Profit saw a slight increase of 22.55%to Rs. 8950.20  millions from Rs. 7303.30 millions.OP of the company witnessed a marginal growth to 13626.70 millions from 11113.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 43181.90 38461.40 12.27 43181.90 38461.40 12.27 157906.00 153808.20 2.66
Other Income 1579.80 1176.80 34.25 1579.80 1176.80 34.25 4567.90 6667.00 -31.48
PBIDT 13626.70 11113.20 22.62 13626.70 11113.20 22.62 42493.70 43779.30 -2.94
Interest 3.10 22.10 -85.97 3.10 22.10 -85.97 270.20 269.30 0.33
PBDT 13623.60 11091.10 22.83 13623.60 11091.10 22.83 40364.50 43510.00 -7.23
Depreciation 1359.50 1283.60 5.91 1359.50 1283.60 5.91 5959.10 5466.20 9.02
PBT 12264.10 9807.50 25.05 12264.10 9807.50 25.05 34405.40 38043.80 -9.56
TAX 3313.90 2504.20 32.33 3313.90 2504.20 32.33 9710.10 9218.00 5.34
Deferred Tax -89.50 -89.30 0.22 -89.50 -89.30 0.22 -400.90 -276.90 44.78
PAT 8950.20 7303.30 22.55 8950.20 7303.30 22.55 24695.30 28825.80 -14.33
Equity 1614.50 1613.80 0.04 1614.50 1613.80 0.04 1614.30 1613.60 0.04
PBIDTM(%) 31.56 28.89 9.21 31.56 28.89 9.21 26.91 28.46 -5.46

Cipla Share Price

1238.30 7.55 (0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×